|
|
| (No se muestran 64 ediciones intermedias de 7 usuarios) |
| Línea 1: |
Línea 1: |
|
| | ==Background== |
| | *STD Prevalence: [[Human papillomavirus|HPV]] > [[Human papillomavirus|HSV-2]] > [[Trichomonas]] > [[Chlamydia trachomatis|Chlamydia]] > [[HIV]] > [[HBV]] > [[Neisseria gonorrhoeae|Gonorrhea]] > [[Syphilis]] |
| | *STD New infections: HPV > Chlamydia > Trichomonas > Gonorrhea > HSV-2 > Syphilis > [[HIV]] > HBV <ref>[http://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf CDC: STI Fact sheet 2013]</ref> |
|
| |
|
| Disorder
| | ==Clinical Features== |
| | {{Genital images male}} |
| | {{Genital images female}} |
|
| |
|
| Clinical
| | ==Differential Diagnosis== |
| | {{STD DDX}} |
|
| |
|
| 1st line
| | ==Evaluation== |
|
| |
|
| Alternative
| | ==Management <ref> https://www.cdc.gov/std/treatment-guidelines/STI-Guidelines-2021.pdf </ref>== |
| | *Consider empiric treatment for [[Gonorrhea]] and [[Chlamydia]]: |
| | **[[Ceftriaxone]] 500 mg IM x1 (1g IM for pts > 150 kg) '''AND''' |
| | **[[Doxycycline]] 100mg PO BID x 7 days (preferred) '''OR''' |
| | **[[Azithromycin]] 1g PO x 1 (alternative regimen) '''OR''' |
| | **[[Azithromycin]] 500 mg PO x 1 and 250mg PO daily x 4 days |
|
| |
|
| Partner
| | *It is important to treat sexual partners for all STDs |
| | **See [[Expedited Partner Therapy]] |
|
| |
|
| In Pregnancy
| | ==Disposition== |
|
| |
|
|
| | ==See Also== |
| N. Gonorrhea
| | *[[Human Papillomavirus (HPV)]] |
| | *[[Pelvic Inflammatory Disease (PID)]] |
| | *[[Ulcerative STDs]] |
| | *[[Penile diagnoses]] |
| | *[[Pelvic pain]] |
| | *[[Expedited Partner Therapy]] |
|
| |
|
| Urethritis/
| | ==External Links== |
|
| |
|
| Cervicitis
| | ==References== |
| | <references/> |
|
| |
|
| M: urethritis with d/c or simply dysuria;can be asymptomatic
| | [[Category:Urology]] [[Category:ID]] [[Category:OBGYN]] |
| | |
| F: purulent discharge; can be asymptomatic
| |
| | |
| Ceftriaxone 125mg IM
| |
| | |
| OR
| |
| | |
| Cefixime (Suprax) 400mg po x1
| |
| | |
|
| |
| | |
| Cipro 500po x 1 – not acceptable in MSM, travel, California, Hawaii
| |
| | |
| OR
| |
| | |
| Spectinomycin 2g IM x 1 OR
| |
| | |
| Azithromycin 2g po x 1
| |
| | |
| Treat and abstinence x 7d after both treated
| |
| | |
| CTX 125mg IM x 1
| |
| | |
|
| |
| N. Gonorrhea
| |
| | |
| Conjunctivitis
| |
| | |
| 2-5d after birth
| |
| | |
| Erythromycin ophthalmic 0.5% x1
| |
| | |
| Tetracycline ophthalmic 1% x1
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| N. Gonorrhea
| |
| | |
| Disseminated
| |
| | |
| (DGI)
| |
| | |
| Petechial, pustular acral skin lesions,
| |
| | |
| Asymmetrical arthralgias, tenosynovitis,
| |
| | |
| Septic arthritis
| |
| | |
| CTX 1g IM/IV q24
| |
| | |
| -continue x24-48h until improvement
| |
| | |
| Cefotax 1g IV q8
| |
| | |
| Spectinomycin 2g IV q12
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| Chlamydia Trachomatis
| |
| | |
| M: urethritis with d/c or simply dysuria; can be asymptomatic
| |
| | |
| F: purulent discharge or cervical bleeding; can be asymptomatic
| |
| | |
| Azithromycin 1g po x1
| |
| | |
| OR
| |
| | |
| Doxycycline 100mg po bid x 7d
| |
| | |
| Erythromycin base 500mg po qid x 7d OR
| |
| | |
| Oflox 300mg po bid x 7d
| |
| | |
| OR
| |
| | |
| Levoflox 500mg po qd x 7days
| |
| | |
| Treat and abstinence x 7d after both treated
| |
| | |
| Azithromycin 1g po x1 or
| |
| | |
| Amoxicillin 500mg po tid x 7d
| |
| | |
| Or
| |
| | |
| Erythro
| |
| | |
|
| |
| Chlamydia
| |
| | |
| Trachomatis
| |
| | |
| Conjunctivitis
| |
| | |
| 5-12d after birth; silver nitrate ophthalmic only rx gonorrhea
| |
| | |
| Erythromycin base 50mg/kg/day PO / 4 doses x14days
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| Chlamydia Trachomatis
| |
| | |
| Pneumonia
| |
| | |
| 1-3months; afebrile, staccato cough with diffuse infiltrates on CXR; peripheral eosinophilia
| |
| | |
| Erythromycin base 50mg/kg/day po / 4 doses x14days
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| Trichamonas vaginalis
| |
| | |
| White, thick discharge
| |
| | |
| Metronidazole 2g po x 1
| |
| | |
| OR
| |
| | |
| Tinidazole 2g po x 1
| |
| | |
| PLUS
| |
| | |
| Azithro 1g po x 1
| |
| | |
|
| |
| | |
| -intravag cream not recommended
| |
| | |
| Metronidazole 500mg bid for 7days; 1-2g po qday x 7d if recurrence
| |
| | |
| OR
| |
| | |
| Topical clotrimazole for metronidazole allergy– not as effective
| |
| | |
| Metronidazole 2g po x 1
| |
| | |
| Rx only if symptomatic but rx partner
| |
| | |
| 1st trimester, Clotrimazole 100mg hs for 7days
| |
| | |
| After 1st trimester, Metronidazole 2g po x 1
| |
| | |
|
| |
| Bacterial Vaginosis
| |
| | |
| Lactobacillus
| |
| | |
| White, fishy discharge
| |
| | |
| Metronidazole 500mg po bid for 7d
| |
| | |
| OR
| |
| | |
| 0.75% Metronidazole gel (one full applicator 5g) intravaginal qd for 5d
| |
| | |
| OR
| |
| | |
| 2% Clindamycin cream 5g qd for 5d
| |
| | |
| Clindamycin 300mg po bid for 7d (recurrence)
| |
| | |
| OR
| |
| | |
| Clindamycin ovules 100mg intravaginally qhs x 3d
| |
| | |
|
| |
| | |
| Exam for STD
| |
| | |
| No rx if nl
| |
| | |
| 1st trimester, metronidazole 250mg po tid x7d
| |
| | |
| After 1st trimester, 500mg po bid for 7days or 250mg po tid x7d or Clinda 300mg po bid x 7d
| |
| | |
|
| |
| Candidiasis
| |
| | |
| (Candida albicans)
| |
| | |
| Cottage cheese;
| |
| | |
| DM or immunocompromised
| |
| | |
| Butoconazole 2% cream 5g intravaginally for 3d
| |
| | |
| OR
| |
| | |
| Butaconazole-sustained 2% intravag x1
| |
| | |
| Clotrimazole 1% 5g cream intravaginally for 7-14d (OTC)
| |
| | |
| OR
| |
| | |
| Clotrimazole 100mg intravag tablet x 7d
| |
| | |
| Candicidal cream if dermatitis present
| |
| | |
| Avoid fluconazole and ketoconazole.
| |
| | |
| Rx with cream for 7d
| |
| | |
|
| |
| | |
|
| |
| Chancroid
| |
| | |
| (H. ducreyi)
| |
| | |
|
| |
| | |
| Painful ulcers with suppurative LAD
| |
| | |
| Azithromycin 1g PO x 1
| |
| | |
| CTX 250mg IM x1
| |
| | |
| Cipro 500mg PO bid x 3days
| |
| | |
| See CDC
| |
| | |
| CTX
| |
| | |
|
| |
| Granuloma Inguinale (Donvanosis)
| |
| | |
| Klebsiella granulomatis
| |
| | |
| Painless lesions without LAD
| |
| | |
| Doxycycline 100mg PO BID x 3wks and until all lesions heald
| |
| | |
| Aizthromycin 1g po q week
| |
| | |
| Ciproflox 750mg PO bid x 3 weeks
| |
| | |
| Bactrim DS 1tab PO BID x 3 wks
| |
| | |
| same
| |
| | |
| Erythromycin base 500mg po qid x 3wks
| |
| | |
|
| |
| Lymphogranuloma Venereum (LGV)
| |
| | |
| C. trach serovars L1-L3
| |
| | |
| Tender, unilateral LAD; can lead to proctitis, fistulas
| |
| | |
| Doxycycline 100mg po bid x 3 weeks
| |
| | |
| Erythromycin base 500mg po qid x 3wks
| |
| | |
| Treat within 60days of exposure with standard Chlamydia Rx
| |
| | |
| Erythromycin base 500mg po qid x 3wks
| |
| | |
|
| |
| Chancre-
| |
| | |
| Primary
| |
| | |
| Syphilis
| |
| | |
| (T. pallidum)
| |
| | |
| Painless ulcer, chancre
| |
| | |
| Benzathine Penicillin G 1.2million U IM x1
| |
| | |
| Doxycycline 100mg po bid x 14d
| |
| | |
| Tetracycline 500mg po qid x 14d
| |
| | |
| CTX 1g IM/IV x 8-10d
| |
| | |
| Azithromycin 2g po x 1?
| |
| | |
| See CDC
| |
| | |
| Penicillin; if allergic desensitize
| |
| | |
|
| |
| Secondary Syphilis
| |
| | |
| (T. pallidum)
| |
| | |
| Skin rash, mucocutaneous lesions, LAD
| |
| | |
|
| |
| | |
|
| |
| | |
| See CDC
| |
| | |
|
| |
| | |
|
| |
| Latent Syphilis
| |
| | |
| Seroreactivity without other evidence of disease
| |
| | |
| Early: Benzathine Penicillin G 2.4 million U IM x1
| |
| | |
| Late: Benzathine Penicillin G 2.4million U IM qweek x 3
| |
| | |
| Doxycycline 100mg po bid x 28d
| |
| | |
| Tetracycline 500mg po qid x 28d
| |
| | |
| See CDC
| |
| | |
|
| |
| | |
|
| |
| Tertiary Syphilis
| |
| | |
| (T. pallidum)
| |
| | |
| Cardiac (aortitis), ophtho (iritis, uveitis), gumma
| |
| | |
| Benzathine Penicillin G 2.4million U IM qweek x 3
| |
| | |
|
| |
| | |
| See CDC
| |
| | |
|
| |
| | |
|
| |
| Neurosyphilis
| |
| | |
| Meningitis, syphilitic eye disease
| |
| | |
| Aqueous crystalline penicillin G 18-24million units/d administered as 3-4million units IV q4h or continuous infusion x 10-14days
| |
| | |
| Procaine penicillin 2.4million units IM qday + Probenecid 500mg po qid
| |
| | |
| BOTH for 10-14d
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| HSV (1st episode)
| |
| | |
| Vesilcular rash
| |
| | |
| Acyclovir 400mg po TID x 7-10day
| |
| | |
| Famciclovir 250mg po TID x 7-10d
| |
| | |
| Valacyclovir 1g PO BID x 7-10d
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| HSV (suppressive)
| |
| | |
|
| |
| | |
| Acyclovir 400mg PO BID
| |
| | |
| Famciclovir 250mg po BID
| |
| | |
| Valacyclovir 500mg PO qday
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| Epididymitis
| |
| | |
| Pain, swelling, inflammation of the epididymis
| |
| | |
| CTX 250mg IM + Doxycyline 100mg po bid x 10d
| |
| | |
| Oflox 300mg po bid x 10d + levoflox 500mg po qday x 10d
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| Epididymorchitis
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| Proctitis
| |
| | |
| Inflammation of the rectum (distal 10-12cm)
| |
| | |
| CTX 125mg IM x1 + Doxy 100mg po bid x 7d
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| PID
| |
| | |
| Sexually active, no other sources and: CMT OR uterine OR adnexal TTP
| |
| | |
| Outpt:
| |
| | |
| Ceftriaxone 250mg IM x1
| |
| | |
| OR
| |
| | |
| Cefoxitin 2g IM in a single dose and probenecid 1g orally administered concurrently in single dose
| |
| | |
| OR
| |
| | |
| Other parenteral 3rd gen cephalosporin eg ceftizoxime or cefotaxime
| |
| | |
| PLUS
| |
| | |
| Doxy 100mg po bid x14d
| |
| | |
| +/-
| |
| | |
| Metronidazole 500mg po bid x 14d
| |
| | |
|
| |
| | |
| Parenteral:
| |
| | |
| Cefotetan 2g IV q12h
| |
| | |
| OR
| |
| | |
| Cefoxitin 2g IV q6h
| |
| | |
| PLUS
| |
| | |
| Doxycyline 100mg IV or PO q12
| |
| | |
| (similar bioavailability)
| |
| | |
|
| |
| | |
| Outpt:
| |
| | |
| Oflox 400mg po bid x 14d
| |
| | |
| OR
| |
| | |
| Levofloxacin 500mg po qday x 14d
| |
| | |
| +/-
| |
| | |
| Metronidazole 500mg po bid x 14d
| |
| | |
|
| |
| | |
| Parenteral:
| |
| | |
| Clinda 900mg IV q8h
| |
| | |
| PLUS
| |
| | |
| Gent load 2mgkg IV; maintenance 1.5mg/kg q8h; single daily dosing may be substituted
| |
| | |
|
| |
| | |
| Oflox 400mg IV q12h
| |
| | |
| OR
| |
| | |
| Levoflox 500mg IV qday
| |
| | |
| +/-
| |
| | |
| Metro 500mg IVq8h
| |
| | |
| OR
| |
| | |
| Unasyn 3g IV q6h
| |
| | |
| PLUS
| |
| | |
| Doxy 100mg IV or PO q12h
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| Scabies
| |
| | |
| Crusted rash, intertiginous areas
| |
| | |
| Permethrin 5% cream applied to all areas of body from neck down and rinsed off after 8-14h
| |
| | |
| Ivermectin 200mcg/kg PO, repeated in 2weeks
| |
| | |
| Lindane (1%) 1 ounce of lotion of 30g of cream applied in thin layer all over from neck down x 8 hours then rinse
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| Pediculosis Pubis
| |
| | |
| Puritic genitalia
| |
| | |
| Permethrin 1% cream: apply to affected areas x 10mins then wash off
| |
| | |
| Malathion lotion 0.5% apply x 8-12h then rinse
| |
| | |
| OR
| |
| | |
| Ivermectin 250mcg/kg PO repeated in 2 weeks
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| *BV: in pregnancy, associated with premature rupture of membranes, chorioamnionitis, preterm birth, postpartum infxn
| |
| | |
| †Test for HIV, syphilis
| |
| | |
|
| |
| | |
|
| |
| | |
| DeBonis
| |
| | |
| Adapted from CDC 2006
| |
| | |
| | |
| | |
| | |
| [[Category:ID]] | |